Sansure Biotech Inc (688289) — Free Cash Flow Generation Index
Sansure Biotech Inc (688289) has a Free Cash Flow Generation Index of -0.06x as of September 2025. Free cash flow of CN¥-3.36 Million represents 0% of operating cash flow (CN¥59.72 Million). Explore capital reinvestment ratio of Sansure Biotech Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sansure Biotech Inc Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Sansure Biotech Inc across 8 annual periods. For the full cash flow conversion analysis, see 688289 cash flow metrics.
Annual Free Cash Flow Generation for Sansure Biotech Inc (2018–2025)
Year-by-year Free Cash Flow Generation Index for Sansure Biotech Inc. Check 688289 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.01x | CN¥-185.81 Million | CN¥183.96 Million | CN¥369.77 Million | ▼ -89.0% |
| 2024 | -0.53x | CN¥-146.66 Million | CN¥274.45 Million | CN¥421.10 Million | ▲ +82.7% |
| 2023 | -3.08x | CN¥-347.81 Million | CN¥112.82 Million | CN¥391.35 Million | ▼ -494.4% |
| 2022 | 0.78x | CN¥2.00 Billion | CN¥2.56 Billion | CN¥558.83 Million | ▼ -2.5% |
| 2021 | 0.80x | CN¥1.50 Billion | CN¥1.88 Billion | CN¥372.86 Million | ▼ -16.4% |
| 2020 | 0.96x | CN¥2.53 Billion | CN¥2.64 Billion | CN¥108.67 Million | ▲ +283.1% |
| 2019 | -0.52x | CN¥-11.74 Million | CN¥22.41 Million | CN¥34.14 Million | ▲ +76.9% |
| 2018 | -2.27x | CN¥-22.84 Million | CN¥10.07 Million | CN¥32.90 Million | — |